These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35092543)

  • 21. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
    Safavi F; Nourbakhsh B; Azimi AR
    Mult Scler Relat Disord; 2020 Aug; 43():102195. PubMed ID: 32460086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing disability and relapses in multiple sclerosis on tele-neurology.
    Moccia M; Lanzillo R; Brescia Morra V; Bonavita S; Tedeschi G; Leocani L; Lavorgna L;
    Neurol Sci; 2020 Jun; 41(6):1369-1371. PubMed ID: 32440979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and mental health in multiple sclerosis patients during the COVID-19 Pandemic.
    Rodríguez-Agudelo Y; Nava-Adán J; Paz-Rodríguez F; Abundes-Corona A; Flores-Rivera J; Corona T
    Mult Scler Relat Disord; 2023 Feb; 70():104487. PubMed ID: 36640561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.
    Barzegar M; Vaheb S; Mirmosayyeb O; Afshari-Safavi A; Nehzat N; Shaygannejad V
    Mult Scler Relat Disord; 2021 Jul; 52():102947. PubMed ID: 33979771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic.
    Sbragia E; Colombo E; Pollio C; Cellerino M; Lapucci C; Inglese M; Mancardi G; Boffa G
    Psychol Health Med; 2022 Feb; 27(2):352-360. PubMed ID: 33899615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Kowalec K; McKay KA; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA;
    Neurology; 2017 Dec; 89(24):2455-2461. PubMed ID: 29117961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
    Landi D; Cola G; Mantero V; Balgera R; Moiola L; Nozzolillo A; Dattola V; Sinisi L; Fantozzi R; Di Lemme S; Centonze D; Mataluni G; Nicoletti CG; Marfia GA
    Mult Scler Relat Disord; 2022 Jan; 57():103345. PubMed ID: 35158454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
    Diržiuvienė B; Mickevičienė D
    Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations among stressors across the lifespan, disability, and relapses in adults with multiple sclerosis.
    Polick CS; Ploutz-Snyder R; Braley TJ; Connell CM; Stoddard SA
    Brain Behav; 2023 Jul; 13(7):e3073. PubMed ID: 37211908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey.
    Zanotto T; Frechette ML; Koziel SR; Hsieh KL; Sosnoff JJ
    Mult Scler Relat Disord; 2021 Sep; 54():103111. PubMed ID: 34303279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Efficacy of Relapsing Multiple Sclerosis Therapies: Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate.
    Hennessy B; Zierhut ML; Kracker H; Keenan A; Sidorenko T
    Mult Scler Relat Disord; 2022 Aug; 64():103908. PubMed ID: 35803162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management.
    Costabile T; Carotenuto A; Lavorgna L; Borriello G; Moiola L; Inglese M; Petruzzo M; Trojsi F; Ianniello A; Nozzolillo A; Cellerino M; Boffa G; Rosa L; Servillo G; Moccia M; Bonavita S; Filippi M; Lanzillo R; Brescia Morra V; Petracca M
    Eur J Neurol; 2021 Oct; 28(10):3375-3383. PubMed ID: 33043560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study.
    Etemadifar M; Abhari AP; Nouri H; Salari M; Maleki S; Amin A; Sedaghat N
    BMC Neurol; 2022 Feb; 22(1):64. PubMed ID: 35193507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Masked face recognition in patients with relapsing-remitting multiple sclerosis during the ongoing COVID-19 pandemic.
    Kuzu Kumcu M; Tezcan Aydemir S; Ölmez B; Durmaz Çelik N; Yücesan C
    Neurol Sci; 2022 Mar; 43(3):1549-1556. PubMed ID: 34988718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of comorbid post traumatic stress disorder on multiple sclerosis in military veterans: A population-based cohort study.
    Leekoff M; Culpepper W; Jin S; Lee-Wilk T; Wallin M
    Mult Scler; 2022 Jul; 28(8):1257-1266. PubMed ID: 34854320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness.
    Barun B; Gabelić T; Adamec I; Babić A; Lalić H; Batinić D; Krbot Skorić M; Habek M
    Mult Scler Relat Disord; 2021 Feb; 48():102704. PubMed ID: 33370649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of multiple sclerosis relapse: The NARCOMS participant perspective.
    Nickerson M; Cofield SS; Tyry T; Salter AR; Cutter GR; Marrie RA
    Mult Scler Relat Disord; 2015 May; 4(3):234-40. PubMed ID: 26008940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.